MMP2 and MMP17 have been implicated in extracellular matrix (ECM) degradation, angiogenesis, and the facilitation of tumor cell migration and invasion, which contribute to disease progression and poor patient outcomes [27,28,29]. Here, MMP17 is linked to neoplasm.